HTL-STREFA was founded in 2000, however the history of safety lancets, that are our speciality, is longer and begins in 1994. In May 2006 our Company was transformed into a joint stock company (S.A.) and finally after a few months, November 2006, it started to be listed on Warsaw Stock Exchange. At the end of 2009, the Company was acquired by the Swedish private equity fund - EQT V.

HTL-STREFA Sp. z o.o. (limited liability company) was founded in May 2000 as a subsidiary of PZ HTL S.A. The Company was designed to continue activities of HTL Sp. z o.o. performed since 1996 - to manufacture devices for capillary blood microsampling. In December 2006, complying with the highest quality standards, the Company started operations in a modern, manufacturing plant in Ozorkow, within Lodz Economic Zone area. Initially the Company was focused on production of safety lancets and elements to electronic pipettes (this activity was stopped in September 2003). In September 2003 the Company started intensive preparations to the production of lancets for personal use, and began to sell them in 2004. Currently the Company, by subsidiary HT Lancet Sp. z o.o., own's a second manufacturing plant in Leczyca.

HTL-STREFA Sp. z o.o. (limited liability company) was transformed into a joint stock company (S.A) in May 2006 and was listed on Warsaw Stock Exchange.

Since then, through funds obtained from the shares issue we are developing dynamically. Particularly crucial for us was 2007. We launched a new needle grindery located at the plant HT Lancet in Łęczyca . In 2007, we've established two foreign subsidiaries, one in the U.S. and the other in Germany. Both subsidiaries are designed to develop sales and marketing subsidiary in the foreign markets. In late 2007, we acquired a significant Swedish competitor from the industry - HaeMedic AB company and therefore our participation in world production of safety lancets exceeded 50 percent.

As a result of a successfully carried out tender for sale of shares, from December 2009 the company belongs to EQT V - an investment fund of EQT Group, which is a leading private equity player.

On 28 September 2010, the shares of HTL-STREFA were excluded from public trading, and from that date the Company is no longer listed on the Warsaw Stock Exchange Main List.